Latest goodwill for ELAT: $4.8B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), ELAT shows a goodwill of $4.8B. That compares with $4.8B in the prior-year period — up 1.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ELAT's goodwill is now $4.8B (was $4.8B) — a 1.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is outperforming or lagging.
Tracking ELAT's goodwill over time shows whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is scaling, shrinking, or reshaping that part of the business. The current reading is $4.8B That compares with $4.8B in the prior-year period — up 1.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this goodwill page, Stockcircle has Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $4.8B) with ownership activity and broader fundamentals.
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s goodwill is $4.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.